Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Serum soluble urokinase-type plasminogen activator receptor levels in male patients with acute exacerbation of schizophrenia — Abdullah Genç (2016) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Serum soluble urokinase-type plasminogen activator receptor levels in male patients with acute exacerbation of schizophrenia
MA
Shared by
Mustafa Akkuş
Serum soluble urokinase-type plasminogen activator receptor levels in male patients with acute exacerbation of schizophrenia
Article
2016
en
Authors
+4 more
AG
Abdullah Genç
TK
Tevfik Kalelioğlu
NK
Nesrin Karamustafalıoğlu
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2019
Increased Serum Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels in FSGS: A Meta-Analysis
Jiwon M. Lee
,
Jae Won Yang
,
Andreas Kronbichler
,
Michael Eisenhut
,
Gaeun Kim
,
Keum Hwa Lee
,
Jae Il Shin
Article
2013
Soluble urokinase–type plasminogen activator receptor as a prognostic biomarker in critically ill patients
Katia Donadello
,
Sabino Scolletta
,
Fabio Silvio Taccone
,
Cecilia Covajes
,
Cristina Santonocito
,
Diego Orbegozo Cortés
,
Daiva Gražulytė
,
Leonardo Gottin
,
Jean Louis Vincent
Article
2020
Circulating Soluble Urokinase-Type Plasminogen Activator Receptor Levels Reflect Renal Function in Newly Diagnosed Patients with Multiple Myeloma Treated with Bortezomib-Based Induction
Evangelos Terpos
,
Ioannis Ntanasis‐Stathopoulos
,
Gerasimos-Petros Papassotiriou
,
Efstathios Kastritis
,
Alexandra Margeli
,
Nikolaos Kanellias
,
Evangelos Eleutherakis‐Papaiakovou
,
Magdalini Migkou
,
Despina Fotiou
,
Μαρία Ρούσσου
,
Maria Gavriatopoulou
,
Panagiotis Malandrakis
,
Erasmia Psimenou
,
Ioannis Papassotiriou
,
Meletios A Dimopoulos
Article
2019
Circulating Soluble Urokinase-Type Plasminogen Activator Receptor Levels Reflect Renal Function in Newly Diagnosed Patients with Multiple Myeloma who Are Treated with Bortezomib-Based Therapy
Αριστέα-Μαρία Παπανώτα
,
Efstathios Kastritis
,
Gerasimos-Petros Papassotiriou
,
Nikolaos Kanellias
,
Evangelos Eleutherakis‐Papaiakovou
,
Alexandra Margeli
,
Magdalini Migkou
,
Ioannis Ntanasis‐Stathopoulos
,
Maria Gavriatopoulou
,
Erasmia Psimenou
,
Ioannis Papassotiriou
,
Meletios A Dimopoulos
,
Evangelos Terpos
Article
2020
Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) As a Biomarker of Renal Outcomes in AL Amyloidosis
Efstathios Kastritis
,
Ioannis Papassotiriou
,
Foteini Theodorakakou
,
Alexandra Margeli
,
Anastasia Barzteliotou
,
Eleni Tsiligkeridou
,
Amalia Andreatou
,
Despina Fotiou
,
Magdalini Migkou
,
Nikolaos Kanellias
,
Ioanna Dialoupi
,
Ioannis Ntanasis‐Stathopoulos
,
Panagiotis Malandrakis
,
Maria Gavriatopoulou
,
Evangelos Terpos
,
Meletios A Dimopoulos
Discussion(0)
No comments yet. Be the first to comment.